Navigation Links
DATATRAK Announces Accreditation Program
Date:6/27/2012

CLEVELAND, June 27, 2012 /PRNewswire/ -- DATATRAK International, Inc. (OTCQX: DATA), a technology and services company focused on global eClinical solutions for the clinical trials industry, today announced the launch of its DATATRAK Accreditation Program (DAP). The DATATRAK Accreditation Program empowers our user communities with the knowledge to use and leverage the DATATRAK ONE™ unified, cloud-based clinical research platform to meet their individual needs and further their corporate initiatives.

Under the DAP, DATATRAK's Clinical and Consulting Services group trains, accredits and supports our Connect Partners and enterprise users on the DATATRAK ONE™ technology. Accreditation is achieved through a standardized training program, including the user's demonstration of a level of knowledge and expertise with each product implementation. Four DATATRAK Connect Partners have already earned accreditation.

"The DAP provides our clients and partners with an industry-wide certification for bringing the DATATRAK ONE™ design and deployment process in-house as well as recognizing members of our Connect Partner program to the rest of the industry as being certified to provide outstanding support services implementing the DATATRAK ONE™ suite," stated Dr. Bill Gluck, VP DATATRAK Clinical and Consulting Services. "This cost-effective implementation method enables our users to configure DATATRAK's suite of products to most efficiently align with their or their customer's workflows and processes thus gaining the greatest value and benefits possible."

About DATATRAK
DATATRAK International is a worldwide technology and services company delivering eClinical solutions and related services for the clinical trials industry. DATATRAK built
'/>"/>

SOURCE DATATRAK International, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. DATATRAK Expands CDISC Registered Solutions Provider Standards
2. NTT DATA Licenses DATATRAK ONE™ for China
3. Golden Meditech Holdings Limited Announces 2011/ 2012 Annual Results
4. Global Information, Inc. Announces New Market Forecasts For Drug Discovery Industry as it Emerges from Recession
5. Omeros Announces Proposed Public Offering of Common Stock
6. Talyst Announces New Automated Medication Packager
7. Thermal Gradient Announces Manufacture of Next Generation DNA Testing Device
8. PrimeraDx Announces Commencement of Product Development Collaboration with Eli Lilly and Company
9. ADVENTRX Announces Manufacturing Agreement With Patheon to Manufacture ANX-188 Drug Product
10. Lexicon Announces Positive Results of LX4211 Phase 2b Trial For Type 2 Diabetes
11. Shire Announces that the US Food and Drug Administration has Responded to its Citizen Petition for Adderall XR and has Approved One Abbreviated New Drug Application for Generic Adderall XR
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2014)... Aug. 19, 2014 Research and Markets ... Drugs - Global Strategic Business Report" report to their ... for Human Growth Hormone Drugs in US$ Million by the ... The report provides separate comprehensive analytics for the US, ... Europe , Asia-Pacific , ...
(Date:8/19/2014)... , Aug. 19, 2014  Boehringer Ingelheim ... Administration (FDA) accepted for review the New Drug ... tiotropium and olodaterol delivered via the Respimat ® ... once-daily maintenance treatment of airflow obstruction in patients ... bronchitis and/or emphysema. Tiotropium + olodaterol FDC will ...
(Date:8/19/2014)... Aug. 19, 2014  Stryker Corporation,s Orthopaedics Division, the Official ... is bringing its message of joint health to golf fans ... this week at The Barclays.  The company,s fan destination ... Spectator Village near the 17 th fairway at the ... on Thursday, August 21 st .    At ...
Breaking Medicine Technology:Global Human Growth Hormone Drugs - Strategic Business Report 2014 2Boehringer Ingelheim Announces U.S. Filing for the Fixed-Dose Combination Tiotropium Plus Olodaterol for Patients with COPD 2Boehringer Ingelheim Announces U.S. Filing for the Fixed-Dose Combination Tiotropium Plus Olodaterol for Patients with COPD 3Boehringer Ingelheim Announces U.S. Filing for the Fixed-Dose Combination Tiotropium Plus Olodaterol for Patients with COPD 4Boehringer Ingelheim Announces U.S. Filing for the Fixed-Dose Combination Tiotropium Plus Olodaterol for Patients with COPD 5Boehringer Ingelheim Announces U.S. Filing for the Fixed-Dose Combination Tiotropium Plus Olodaterol for Patients with COPD 6Boehringer Ingelheim Announces U.S. Filing for the Fixed-Dose Combination Tiotropium Plus Olodaterol for Patients with COPD 7Boehringer Ingelheim Announces U.S. Filing for the Fixed-Dose Combination Tiotropium Plus Olodaterol for Patients with COPD 8Stryker, The Official Joint Replacement Products Of The PGA TOUR, Welcomes Golf Fans To Its Home State Of New Jersey For The Barclays 2Stryker, The Official Joint Replacement Products Of The PGA TOUR, Welcomes Golf Fans To Its Home State Of New Jersey For The Barclays 3Stryker, The Official Joint Replacement Products Of The PGA TOUR, Welcomes Golf Fans To Its Home State Of New Jersey For The Barclays 4Stryker, The Official Joint Replacement Products Of The PGA TOUR, Welcomes Golf Fans To Its Home State Of New Jersey For The Barclays 5
... 31, 2011 Boston Scientific Corporation (NYSE: ... Food and Drug Administration (FDA) has approved its ... and delivery of diagnostic, embolic and therapeutic materials ... be used by interventional radiologists for minimally invasive ...
... Endologix, Inc. (Nasdaq: ELGX ), ... announced today the publication of favorable clinical results ... of abdominal aortic aneurysm (EVAR).  The peer-reviewed article ... trial, with successful aneurysm exclusion in all patients, ...
Cached Medicine Technology:Boston Scientific Announces FDA Approval of Renegade® HI-FLO™ Fathom® Pre-Loaded System 2Boston Scientific Announces FDA Approval of Renegade® HI-FLO™ Fathom® Pre-Loaded System 3Boston Scientific Announces FDA Approval of Renegade® HI-FLO™ Fathom® Pre-Loaded System 4Endologix Announces Favorable Clinical Results for Nellix Technology 2Endologix Announces Favorable Clinical Results for Nellix Technology 3
(Date:8/20/2014)... BCC Research ( http://www.bccresearch.com ) reveals ... DETECTORS: TECHNOLOGIES AND GLOBAL MARKETS , the global ... grow to $15.2 billion by 2019, with a ... Increasing industrialization is driving significant growth across ... range of industrial applications such as military and ...
(Date:8/20/2014)... San Mateo, CA (PRWEB) August 20, 2014 ... their newest product—the Really Little Green Pouch —to ... easier to feed babies and toddlers homemade foods. ... says Little Green Pouch co-founder Maggie Crawford. She ... their kids, to limit exposure to things like pesticides ...
(Date:8/20/2014)... 2014 "I decided that there needed ... an optimal manner without the hassles associated with using ... , The patent-pending DR. GATES ORAL-HYGIENE TOOL provides an ... It promotes good oral hygiene and fresh breath, and ... Convenient, compact, affordable, eco-friendly and easy to use, the ...
(Date:8/20/2014)... been chosen by Plymouth University to be an official ... 2009 to raise awareness of, and funding for, scientific ... tumour patients. , A range of events and activities ... charity, and members of staff and students, as well ... fundraise and volunteer. The involvement of the wider community ...
(Date:8/20/2014)... Fresh from the cradle of a world-class running city, an ... , Urbini, a new collection of versatile baby gear from ... jogger to its lineup. , The Avi has been in ... the latest racing styles and a set of features to ... a swift, smooth ride on runs, power-walks and causal strolls. ...
Breaking Medicine News(10 mins):Health News:Global Market for Photonic Sensors and Detectors to Reach $15.2 Billion in 2019 2Health News:Global Market for Photonic Sensors and Detectors to Reach $15.2 Billion in 2019 3Health News:Little Green Pouch Launches New Product to Help Health-conscious Parents Reduce Babies’ Eco-footprint 2Health News:Plymouth University chooses Brain Tumour Research as official charity 2Health News:Urbini Breezes Through Summer with New Jogging Stroller 2
... available since the middle of 2011 as a treatment ... early benefit assessment pursuant to the "Act on the ... German Institute for Quality and Efficiency in Health Care ... added benefit in comparison with the previous standard therapy. ...
... study, initiated by the Swiss researchers and published in ... in the brain. Anxiety disorders constitute a complex ... Patients suffering from such disorders fear certain situations or ... the real danger they present. The amygdala, a ...
... -- The presence of circulating tumor cells in the blood ... have just been diagnosed with inflammatory breast cancer, according to ... research shows that these stray tumor cells may signal that ... even before imaging reveals any metastases. The results will ...
... Kathleen Doheny HealthDay Reporter , THURSDAY, Dec. ... especially starches, may boost the risk of breast cancer ... public health doctoral student at the University of California, ... carbohydrates, particularly starchy foods such as potatoes, that breast ...
... Biology (FASEB) is pleased to announce the addition of ... the Society for Pediatric Research, which will bring the ... very dynamic groups representing extremely important areas of research, ... said FASEB President Joseph C. LaManna, PhD. "We welcome ...
... a University of Notre Dame researcher, is one of the coauthors ... scientists in academia and industry that calls for strong steps to ... bacteria. The group issued a priority list of steps that need ... The paper is an outgrowth of a meeting the group ...
Cached Medicine News:Health News:Boceprevir: Indication of added benefit for specific patients 2Health News:Boceprevir: Indication of added benefit for specific patients 3Health News:The cortex plays an essential part in emotional learning 2Health News:Circulating tumor cells not linked to survival in newly diagnosed inflammatory breast cancer 2Health News:Circulating tumor cells not linked to survival in newly diagnosed inflammatory breast cancer 3Health News:Starchy Foods May Boost Risk of Breast Cancer Recurrence 2Health News:Starchy Foods May Boost Risk of Breast Cancer Recurrence 3Health News:New paper calls for strong steps to tackle antibiotic resistance 2
... multifunction plate reader that offers four different ... time-resolved fluorescence, high-perfomance luminescence and absorbance. The ... that deliver reagent at the point of ... can be performed easily and allowing the ...
This new dedicated VICTOR2 model is for fluorescence and luminescence measurements....
... VICTOR2 multilabel counter with ... stacker and robot loading ... density time-resolved fluorescence, luminescence ... of the instrument is ...
This is the modular manually operated VICTOR2 multilabel counter, with the addition of a xenon flash lamp for time-resolved fluorescence counting. Along with this option comes flash absorbance and du...
Medicine Products: